FDA Expanded Access benefits heavily pretreated patients, especially childrenMarch 4, 2019Practice ManagementCNS/Brain CancerBreast CancerLung Cancer
Model shows nivolumab plus ipilimumab cost effective in mRCCFebruary 25, 2019Practice ManagementGenitourinary CancerRenal Cell CarcinomaImmuno-oncology
Talk about déjà vu: Senators set to re-enact drug price hearing of 60 years agoFebruary 25, 2019Practice Management
Health spending: Boomers will spike costs, but growing uninsured will soften their impactFebruary 20, 2019Practice Management
CMS proposes coverage of CAR T-cell therapy in trialsFebruary 15, 2019Practice ManagementImmuno-oncologyImmunotherapyGene Therapy
